In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes John Khoury, Founder of Project Farma, to unpack how the standards for advanced therapies are shifting.

John reflects on why infrastructure planning, automation, and comparability studies can’t be left until late-stage development. They explore how CGT companies can reduce manufacturing risk by running development activities in parallel, why early investment in platform approaches matters, and how outdated assumptions about regulatory flexibility may be slowing progress. For developers aiming to compete at scale, these early decisions are quickly becoming non-negotiable.

Connect with John: https://www.linkedin.com/in/john-khoury-017b592/